Annual Current Liabilities
$3.49 M
-$856.70 K-19.71%
01 December 2023
Summary:
TransCode Therapeutics annual total current liabilities is currently $3.49 million, with the most recent change of -$856.70 thousand (-19.71%) on 01 December 2023. During the last 3 years, it has risen by +$956.50 thousand (+37.75%). RNAZ annual current liabilities is now -19.71% below its all-time high of $4.35 million, reached on 31 December 2022.RNAZ Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$2.28 M
-$1.22 M-34.79%
01 September 2024
Summary:
TransCode Therapeutics quarterly total current liabilities is currently $2.28 million, with the most recent change of -$1.22 million (-34.79%) on 01 September 2024. Over the past year, it has dropped by -$1.21 million (-34.57%). RNAZ quarterly current liabilities is now -59.20% below its all-time high of $5.60 million, reached on 01 September 2023.RNAZ Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -34.6% |
| 3 y3 years | +37.8% | -9.9% |
| 5 y5 years | +5449.4% | - |
RNAZ Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.7% | +37.8% | -59.2% | +32.2% |
| 5 y | 5 years | -19.7% | +5449.4% | -59.2% | +464.1% |
| alltime | all time | -19.7% | +5449.4% | -59.2% | +464.1% |
TransCode Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.28 M(-34.8%) |
| June 2024 | - | $3.50 M(+29.4%) |
| Mar 2024 | - | $2.71 M(-22.5%) |
| Dec 2023 | $3.49 M(-19.7%) | $3.49 M(-37.6%) |
| Sept 2023 | - | $5.60 M(+58.9%) |
| June 2023 | - | $3.52 M(-35.3%) |
| Mar 2023 | - | $5.45 M(+25.4%) |
| Dec 2022 | $4.35 M | $4.35 M(+15.3%) |
| Sept 2022 | - | $3.77 M(+118.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $1.73 M(-6.6%) |
| Mar 2022 | - | $1.85 M(-27.0%) |
| Dec 2021 | $2.53 M(+525.9%) | $2.53 M(+14.9%) |
| Sept 2021 | - | $2.20 M(+43.8%) |
| June 2021 | - | $1.53 M(+94.4%) |
| Mar 2021 | - | $788.80 K(+94.8%) |
| Dec 2020 | $404.90 K(+543.7%) | - |
| Dec 2020 | - | $404.90 K |
| Dec 2019 | $62.90 K | - |
FAQ
- What is TransCode Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly current liabilities year-on-year change?
What is TransCode Therapeutics annual total current liabilities?
The current annual current liabilities of RNAZ is $3.49 M
What is the all time high annual current liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total current liabilities is $4.35 M
What is TransCode Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RNAZ is $2.28 M
What is the all time high quarterly current liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total current liabilities is $5.60 M
What is TransCode Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RNAZ quarterly total current liabilities has changed by -$1.21 M (-34.57%)